Pfizer, Allergan close to $150 billion merger: reports

SHARE Pfizer, Allergan close to $150 billion merger: reports

Pfizer Inc. and Botox-maker Allergan Plc could announce a $150 billion merger plan as soon as Monday, according to reports.

The companies’ boards were expected to vote Sunday on a plan that would create a pharmaceutical giant and possibly shift its headquarters to Europe for tax savings, the New York Times and Wall Street Journal reported Sunday.

Pfizer completed its $15 billion deal for Hospira, the Lake Forest maker of injectable drugs, in September.

A merger could enable Viagra maker Pfizer, the world’s second-biggest drugmaker by revenue, to surpass Switzerland’s Novartis AG and regain the industry’s top spot. It would also add Allergan’s brand-name medicines for eye conditions, infections and heart disease to Pfizer’s extensive portfolio of vaccines and drugs for cancer, pain, erectile dysfunction and other conditions.

The Latest
Seven lawsuits filed by former football players will be temporarily consolidated with a lawsuit filed by former head coach Pat Fitzgerald during the pretrial process.
The city is willing to put private interests ahead of public benefit and cheer on a wrongheaded effort to build a massive domed stadium — that would be perfect for Arlington Heights — on Chicago’s lakefront.
The Art Institute of Chicago, responding to allegations by New York prosecutors, says it’s ‘factually unsupported and wrong’ that Egon Schiele’s ‘Russian War Prisoner’ was looted by Nazis from the original owner’s heirs.
April Perry has instead been appointed to the federal bench. But it’s beyond disgraceful that Vance, a Trump acolyte, used the Senate’s complex rules to block Perry from becoming the first woman in the top federal prosecutor’s job for the Northern District of Illinois.